Haemophilus B Conjugate (Prp Omp) Vaccine

Haemophilus influenzae type B (Hib) is a bacteria that can cause serious illness, including breathing problems or meningitis. Hib infection usually affects children and can be fatal.

Haemophilus B conjugate (PMP-OMP) vaccine is used to help prevent this disease in children. This vaccine is given to children between the ages of 2 months and 6 years old.

The vaccine works by exposing your child to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body, and will not protect against other types of influenza.

Haemophilus B conjugate vaccine is not for use in children younger than 6 weeks or older than 6 years.

Like any vaccine, haemophilus B conjugate vaccine may not provide protection from disease in every person.

Your child should not receive this vaccine if he or she has ever had an allergic reaction to a haemophilus B or meningococcal vaccine.

This vaccine is injected into a muscle. Your child will receive this injection in a doctor's office or clinic setting.

This vaccine is given in a series of shots. The first shot is usually given when the child is 2 months old. The booster shots are then given at 4 months and 6 months of age, and again at 12 to 15 months of age.

For children who do not start this series of shots before 15 months of age, the vaccine is usually given as a one-time injection. Unless your doctor's tells you otherwise, you will not need a booster vaccine.

Your child's individual booster schedule may be different from these guidelines. Follow your doctor's instructions or the schedule recommended by the health department of the state you live in.

Your doctor may recommend treating fever and pain with an aspirin free pain reliever such as acetaminophen (Tylenol) or ibuprofen (Motrin, Advil, and others) when the shot is given and for the next 24 hours. Follow the label directions or your doctor's instructions about how much of this medicine to give your child.

It is especially important to prevent fever from occurring in a child who has a seizure disorder such as epilepsy.

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Get emergency medical help if your child has signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shot caused any side effects.

Becoming infected with haemophilus B is much more dangerous to your child's health than receiving this vaccine. Like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.

Call your doctor at once if your child has:

• high fever (within a few hours or a few days after the vaccine);

• seizure (blackout-out or convulsions); or

• fussiness, irritability, crying for an hour or longer.

Common side effects may include:

• diarrhea; or

• pain, swelling, or redness where the shot was given.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.

Usual Pediatric Dose for Haemophilus influenzae Prophylaxis:

2 to 14 Months of Age:
Infants 2 to 14 months of age should receive 0.5 mL intramuscularly ideally beginning at 2 months of age followed by 0.5 mL 2 months later (or as soon as possible thereafter). When the primary two-dose regimen is completed before 12 months of age, a booster dose is required.

Infants born prematurely, regardless of birth weight, should be vaccinated at the same chronological age and according to the same schedule and precautions as full-term infants and children.

Children 15 months of age and older previously unvaccinated against Hib disease should receive a single 0.5 mL dose intramuscularly .

Data not available

Haemophilus b conjugate (PRP-OMP) vaccine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are not data in human pregnancy. Haemophilus b conjugate (PRP-OMP) vaccine is not recommended for use in a pregnant woman and is not approved for use in children 6 years of age or older.